Venrock Adviser as of March 31, 2026
Portfolio Holdings for Venrock Adviser
Venrock Adviser holds 33 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 26.7 | $715M | 8.5M | 84.17 | |
| Erasca (ERAS) | 9.9 | $265M | 16M | 16.18 | |
| Oruka Therapeutics (ORKA) | 7.6 | $204M | 4.1M | 49.05 | |
| Spyre Therapeutics Com New (SYRE) | 6.9 | $186M | 3.7M | 50.44 | |
| Kalvista Pharmaceuticals (KALV) | 4.9 | $130M | 6.5M | 20.13 | |
| Dianthus Therapeutics (DNTH) | 3.7 | $99M | 1.2M | 83.92 | |
| Damora Therapeutics Com New (DMRA) | 3.5 | $93M | 3.6M | 25.90 | |
| Ocular Therapeutix (OCUL) | 3.3 | $88M | 10M | 8.47 | |
| Cogent Biosciences (COGT) | 2.9 | $77M | 2.0M | 38.49 | |
| Miragen Therapeutics (VRDN) | 2.8 | $76M | 3.9M | 19.56 | |
| Savara (SVRA) | 2.8 | $75M | 14M | 5.46 | |
| Enliven Therapeutics (ELVN) | 2.5 | $68M | 1.7M | 39.20 | |
| Oric Pharmaceuticals (ORIC) | 2.0 | $55M | 4.3M | 12.67 | |
| Vor Biopharma Com New (VOR) | 2.0 | $54M | 3.0M | 17.84 | |
| Maze Therapeatics (MAZE) | 1.8 | $48M | 1.6M | 29.85 | |
| Cytomx Therapeutics (CTMX) | 1.8 | $47M | 10M | 4.70 | |
| Jade Biosciences Com New (JBIO) | 1.7 | $45M | 3.2M | 14.05 | |
| Dyne Therapeutics (DYN) | 1.5 | $39M | 2.2M | 18.13 | |
| Crescent Biopharma (CBIO) | 1.5 | $39M | 2.1M | 18.37 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.4 | $38M | 6.4M | 5.95 | |
| Relmada Therapeutics (RLMD) | 1.3 | $34M | 4.8M | 6.96 | |
| Engene Holdings (ENGN) | 1.2 | $33M | 4.8M | 6.81 | |
| Tenax Therapeutics Com New (TENX) | 1.0 | $27M | 1.7M | 15.99 | |
| Adlai Nortye Sponsored Ads (ANL) | 0.8 | $22M | 3.2M | 6.92 | |
| Century Therapeutics (IPSC) | 0.7 | $20M | 8.7M | 2.26 | |
| Cullinan Oncology (CGEM) | 0.7 | $20M | 1.4M | 14.21 | |
| Cybin Com New (HELP) | 0.7 | $19M | 3.9M | 4.80 | |
| Surrozen Com New (SRZN) | 0.7 | $18M | 633k | 29.13 | |
| Septerna (SEPN) | 0.5 | $12M | 506k | 24.03 | |
| Korro Bio (KRRO) | 0.4 | $11M | 1.0M | 11.32 | |
| Alto Neuroscience Com Shs (ANRO) | 0.4 | $11M | 500k | 22.48 | |
| Artiva Biotherapeutics (ARTV) | 0.4 | $10M | 1.6M | 6.44 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.1 | $1.4M | 331k | 4.13 |
